India to United States: Tacrolimus Export Trade Route

The India to United States Tacrolimus corridor is one of India's established pharmaceutical export routes, with 743 shipments documented worth a combined $83.3M USD. The route is dominated by ALKEM LABORATORIES LIMITED, which alone accounts for roughly 36% of all export value, reflecting the consolidated nature of India's tacrolimus manufacturing sector.

Across 25 active suppliers, the average shipment value stands at $112.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with tacrolimus's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 31.6%, placing it at rank #12 among India's top tacrolimus export destinations globally.

On the import side, key buyers of Indian tacrolimus in United States include ASCEND LABORATORIES LLC, SANDOZ INC C O EXEL INC, SANDOZ INC. C/O EXEL, INC. and 55 others. ASCEND LABORATORIES LLC is the single largest importer with 41 shipments valued at $28.2M USD.

India's tacrolimus exports to United States are driven primarily by a handful of large-scale manufacturers. ALKEM LABORATORIES LIMITED with 88 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 25 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ALKEM LABORATORIES LIMITED, SANDOZ PRIVATE LIMITED, INTAS PHARMACEUTICALS LIMITED — together account for 76% of total trade value on this route. The average shipment value of $112.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as tacrolimus 1mg 100hgc bo us material no.- 44010293 and tacrolimus capsules usp 1mg (each caps cont. tacrolimus 1mg) [6240 pack x 100's](batch no. 23123426 mfg dt. 11/23 exp d, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ASCEND LABORATORIES LLC is the largest importer with 41 shipments worth $28.2M USD — representing 34% of all tacrolimus imports from India on this route. A total of 58 buyers are active on this corridor.